SPRO
Spero Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.09 / 10
Outperform
Spero Therapeutics shows a fundamental score of 7.1/10, indicating solid strength. Key positives include a healthy interest coverage ratio (EBIT/Interest expense = 15.48) and favorable Revenue-MV, Profit-MV, Cash-MV, and Asset-MV differentials. However, year-over-year revenue growth is negative (-22.55%), and the days sales outstanding is elevated at 266.02, both of which are concerns. Overall, the fundamentals are encouraging but not without flaws.
Analysis Checks(7/10)
Revenue-MV
Value-1.32
Score3/3
Weight18.55%
1M Return10.54%
Value-1.32
Score3/3
Weight18.55%
1M Return10.54%
Days sales outstanding
Value266.02
Score0/3
Weight-6.55%
1M Return-5.18%
Value266.02
Score0/3
Weight-6.55%
1M Return-5.18%
Net income-Revenue
Value-0.17
Score2/3
Weight14.80%
1M Return8.45%
Value-0.17
Score2/3
Weight14.80%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.48%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.48%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight27.42%
1M Return13.15%
Value-0.50
Score3/3
Weight27.42%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value-22.55
Score1/3
Weight-1.08%
1M Return-0.79%
Value-22.55
Score1/3
Weight-1.08%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight14.79%
1M Return8.45%
Value0.46
Score2/3
Weight14.79%
1M Return8.45%
PB-ROE
Value0.89
Score3/3
Weight20.05%
1M Return12.83%
Value0.89
Score3/3
Weight20.05%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value-22.55
Score1/3
Weight-1.04%
1M Return-0.76%
Value-22.55
Score1/3
Weight-1.04%
1M Return-0.76%
Cash-MV
Value1.26
Score2/3
Weight14.54%
1M Return8.41%
Value1.26
Score2/3
Weight14.54%
1M Return8.41%
Revenue-MV
Value-1.32
Score3/3
Weight18.55%
1M Return10.54%
Value-1.32
Score3/3
Weight18.55%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value-22.55
Score1/3
Weight-1.08%
1M Return-0.79%
Value-22.55
Score1/3
Weight-1.08%
1M Return-0.79%
Days sales outstanding
Value266.02
Score0/3
Weight-6.55%
1M Return-5.18%
Value266.02
Score0/3
Weight-6.55%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight14.79%
1M Return8.45%
Value0.46
Score2/3
Weight14.79%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight14.80%
1M Return8.45%
Value-0.17
Score2/3
Weight14.80%
1M Return8.45%
PB-ROE
Value0.89
Score3/3
Weight20.05%
1M Return12.83%
Value0.89
Score3/3
Weight20.05%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.48%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.48%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-22.55
Score1/3
Weight-1.04%
1M Return-0.76%
Value-22.55
Score1/3
Weight-1.04%
1M Return-0.76%
Asset-MV
Value-0.50
Score3/3
Weight27.42%
1M Return13.15%
Value-0.50
Score3/3
Weight27.42%
1M Return13.15%
Cash-MV
Value1.26
Score2/3
Weight14.54%
1M Return8.41%
Value1.26
Score2/3
Weight14.54%
1M Return8.41%
Is SPRO undervalued or overvalued?
- SPRO scores 7.09/10 on fundamentals and holds a Discounted valuation at present. Backed by its -63.20% ROE, -108.11% net margin, -3.11 P/E ratio, 5.14 P/B ratio, and -1087.50% earnings growth, these metrics solidify its Outperform investment rating.
